Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Anesth Analg. 2020 Dec;131(6):1901–1910. doi: 10.1213/ANE.0000000000005085

Table 2.

Clinical impact: description of cohort and medication administration. “Differential RR” is the relative risk of receiving a medication in the high-delirium-risk group after AWOL-S implementation, after controlling for secular trends using rates of medication use in the low-risk group.

Baseline AWOL-S p
Low risk High risk Low risk High risk Before vs after AWOL-S
Number of surgical encounters 7,368 2,049 13,704 3,630
Age (years) 53 ± 16 67 ± 12 53 ± 16 68 ± 12 0.85
Unable to spell WORLD backward 10% 35% 13% 38% <0.001
Not oriented to place 2.5% 15% 1.7% 13% <0.001
High illness severity (ASA 3+) 29% 77% 29% 76% 0.12
Surgery-specific delirium risk Low 74% 7.4% 74% 7.1% 0.32
Moderate 23% 70% 23% 70%
High 2.6% 23% 3.0% 23%
Delirium in first 7 postop days 1.3% 10% 1.3% 11.4% 0.31
Perioperative medication use Differential RR p
Any benzodiazepine 54% 37% 50% 33% 0.95 [0.88–1.03] 0.24
Midazolam 54% 36% 50% 32% 0.95 [0.87–1.03] 0.19
Lorazepam 1.8% 2.0% 1.7% 1.8% 0.98 [0.63–1.53] 0.63
Any anticholinergic 12% 8.6% 12% 6.5% 0.79 [0.64–0.97] 0.02
Diphenhydramine 1.7% 1.5% 2.2% 1.4% 0.74 [0.45–1.22] 0.23
Meperidine 2.8% 2.0% 3.9% 1.9% 0.68 [0.45–1.03] 0.07
Prochlorperazine 6.6% 4.5% 5.1% 3.1% 0.89 [0.67–1.19] 0.44
Promethazine 0.1% 0.1% 0.06% 0.03% 0.52 [0.04–7.01] 0.63
Scopolamine 2.1% 1.1% 1.7% 0.6% 0.72 [0.39–1.34] 0.31